{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:00:03Z","timestamp":1777946403418,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10792-017-0786-x","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T02:19:02Z","timestamp":1513563542000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens\u2013Johnson syndrome"],"prefix":"10.1007","volume":"39","author":[{"given":"Hyeon Jeong","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mee Kum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Yul","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Ueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2788-1851","authenticated-orcid":false,"given":"Kyung Chul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"key":"786_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ajo.2016.06.039","volume":"169","author":"HN Saeed","year":"2016","unstructured":"Saeed HN, Kohanim S, Le HG et al (2016) Stevens\u2013Johnson syndrome and corneal ectasia: management and a case for association. Am J Ophthalmol 169:276\u2013281","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"786_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jtos.2015.10.002","volume":"14","author":"S Kohanim","year":"2016","unstructured":"Kohanim S, Palioura S, Saeed HN et al (2016) Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis\u2014a comprehensive review and guide to therapy. I. Systemic disease. Ocul Surf 14(1):2\u201319","journal-title":"Ocul Surf"},{"issue":"8","key":"786_CR3","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ophtha.2016.04.041","volume":"123","author":"DG Gregory","year":"2016","unstructured":"Gregory DG (2016) New grading system and treatment guidelines for the acute ocular manifestations of Stevens\u2013Johnson syndrome. Ophthalmology 123(8):1653\u20131658","journal-title":"Ophthalmology"},{"issue":"2","key":"786_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0161-6420(01)00900-9","volume":"109","author":"T John","year":"2002","unstructured":"John T, Foulks GN, John ME et al (2002) Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 109(2):351\u2013360","journal-title":"Ophthalmology"},{"issue":"2","key":"786_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","volume":"26","author":"YS Chang","year":"2007","unstructured":"Chang YS, Huang FC, Tseng SH et al (2007) Erythema multiforme, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26(2):123\u2013129","journal-title":"Cornea"},{"key":"786_CR6","doi-asserted-by":"publisher","first-page":"2087578","DOI":"10.1155\/2017\/2087578","volume":"2017","author":"P Jongkhajornpong","year":"2017","unstructured":"Jongkhajornpong P, Lekhanont K, Siriyotha S et al (2017) Factors contributing to long-term severe visual impairment in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. J Ophthalmol 2017:2087578","journal-title":"J Ophthalmol"},{"issue":"1","key":"786_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/ICO.0b013e318158f6ad","volume":"27","author":"HS Uy","year":"2008","unstructured":"Uy HS, Chan PS, Ang RE (2008) The topical bevacizumab and ocular surface neovascularization in patients with Stevens\u2013Johnson syndrome. Cornea 27(1):70\u201373","journal-title":"Cornea"},{"issue":"5","key":"786_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ophtha.2004.11.035","volume":"112","author":"MA Pascuale Di","year":"2005","unstructured":"Di Pascuale MA, Espana EM, Liu DT et al (2005) Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112(5):904\u2013912","journal-title":"Ophthalmology"},{"issue":"4","key":"786_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1167\/iovs.03-0940","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Masli S, Ng TF et al (2004) Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. Invest Ophthalmol Vis Sci 45(4):1117\u20131124","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"786_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/archopht.1983.01040010640024","volume":"101","author":"K Phillips","year":"1983","unstructured":"Phillips K, Arffa R, Cintron C et al (1983) Effect of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol 101(4):640\u2013643","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"786_CR11","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/archopht.120.8.1063","volume":"120","author":"BK Ambati","year":"2002","unstructured":"Ambati BK, Joussen AM, Ambati J et al (2002) Angiostatin inhibits and regresses corneal neovascularization. Arch Ophthalmol 120(8):1063\u20131068","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"786_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/archopht.1989.01070020575043","volume":"107","author":"G Corrent","year":"1989","unstructured":"Corrent G, Roussel TJ, Tseng SCG et al (1989) Promation of graft survival by photothrombotic occlusion of corneal neovascularization. Arch Ophthalmol 107(10):1501\u20131506","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"786_CR13","first-page":"2148","volume":"41","author":"CT Pillai","year":"2000","unstructured":"Pillai CT, Dua HS, Hossain P (2000) Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci 41(8):2148\u20132153","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"786_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1097\/ICO.0b013e31817c41e3","volume":"27","author":"CX Qian","year":"2008","unstructured":"Qian CX, Bahar I, Levinger E et al (2008) Superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization. Cornea 27(9):1090\u20131092","journal-title":"Cornea"},{"issue":"6","key":"786_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/bjo.2003.035071","volume":"88","author":"BJ Brooks","year":"2004","unstructured":"Brooks BJ, Ambati BK, Marcus DM et al (2004) Photodynamic therapy for corneal neovascularisation and lipid degeneration. Br J Ophthalmol 88(6):840","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"786_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ajo.2007.05.028","volume":"144","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, You IC, Kang IS et al (2007) Photodynamic therapy with verteporfin for corneal neovascularization. Am J Ophthalmol 144(3):390\u2013395","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"786_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"JH Chang","year":"2012","unstructured":"Chang JH, Garg NK, Lunde E et al (2012) Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol 57(5):415\u2013429","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"786_CR18","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1167\/iovs.14-15257","volume":"55","author":"YC Kim","year":"2014","unstructured":"Kim YC, Grossniklaus HE, Edelhauser HF et al (2014) Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization. Invest Ophthalmol Vis Sci 55(11):7376\u20137386","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"786_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ajo.2006.01.085","volume":"142","author":"O Tatar","year":"2006","unstructured":"Tatar O, Adam A, Shinoda K et al (2006) Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am J Ophthalmol 142(1):95\u2013104","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"786_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1755-3768.2008.01399.x","volume":"87","author":"IC You","year":"2009","unstructured":"You IC, Kang IS, Lee SH, Yoon KC (2009) Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization. Acta Ophthalmol 87(6):653\u2013658","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"786_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","volume":"27","author":"I Bahar","year":"2008","unstructured":"Bahar I, Kaiserman I, McAllum P et al (2008) Subconjunctival bevacizumab injection for corneal neovascularization. Cornea 27(2):142\u2013147","journal-title":"Cornea"},{"issue":"1","key":"786_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/ICO.0b013e3181dc81a0","volume":"30","author":"IC You","year":"2011","unstructured":"You IC, Im SK, Lee SH, Yoon KC (2011) Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization. Cornea 30(1):30\u201333","journal-title":"Cornea"},{"issue":"7","key":"786_CR23","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","volume":"114","author":"C Sotozono","year":"2007","unstructured":"Sotozono C, Ang LP, Koizumi N et al (2007) New grading system for the evaluation of chronic ocular manifestations in patients with Stevens\u2013Johnson syndrome. Ophthalmology 114(7):1294\u20131302","journal-title":"Ophthalmology"},{"issue":"2","key":"786_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ophtha.2014.08.013","volume":"122","author":"DH Kim","year":"2015","unstructured":"Kim DH, Yoon KC, Seo KY et al (2015) The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens\u2013Johnson syndrome. Ophthalmology 122(2):254\u2013264","journal-title":"Ophthalmology"},{"issue":"2","key":"786_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/ICO.0000000000000708","volume":"35","author":"HS Lee","year":"2016","unstructured":"Lee HS, Mayumi U, Yoon KC et al (2016) Analysis of ocular manifestation and genetic association of allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in south Korea. Cornea 35(2):199\u2013204","journal-title":"Cornea"},{"issue":"10","key":"786_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","volume":"247","author":"Y Koenig","year":"2009","unstructured":"Koenig Y, Bock F, Horn F et al (2009) Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 247(10):1375\u20131382","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"786_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaapos.2011.12.153","volume":"16","author":"S Kesarwani","year":"2012","unstructured":"Kesarwani S, Sahu SK, Basu S (2012) Bilateral response after unilateral subconjunctival bevacizumab injection in a child with Stevens\u2013Johnson syndrome. J AAPOS 16(3):309\u2013311","journal-title":"J AAPOS"},{"issue":"11","key":"786_CR28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/ICO.0b013e3181cb83f2","volume":"30","author":"HS Uy","year":"2011","unstructured":"Uy HS, Yu EN, Sua AS (2011) Histologic findings of bevacizumab-treated human conjunctiva in Stevens\u2013Johnson syndrome. Cornea 30(11):1273\u20131276","journal-title":"Cornea"},{"issue":"10","key":"786_CR29","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","volume":"245","author":"M Erdurmus","year":"2007","unstructured":"Erdurmus M, Totan Y (2007) Subconjunctival bevacizumab for corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 245(10):1577\u20131579","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"786_CR30","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","volume":"115","author":"SW Kim","year":"2008","unstructured":"Kim SW, Ha BJ, Kim EK et al (2008) The effect of topical bevacizumab on corneal neovascularization. Ophthalmology 115(6):e33\u2013e38","journal-title":"Ophthalmology"},{"issue":"Suppl 7","key":"786_CR31","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.5301\/ejo.5000050","volume":"22","author":"D Veritti","year":"2012","unstructured":"Veritti D, Vergallo S, Lanzetta P (2012) Triple therapy for corneal neovascularization: a case report. Eur J Ophthalmol 22(Suppl 7):S126\u2013S128","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"786_CR32","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/ICO.0000000000001016","volume":"35","author":"RY Kim","year":"2016","unstructured":"Kim RY, Chung SK, Kim MS, Ra H (2016) Effects of combined photodynamic therapy and topical bevacizumab treatment on corneal neovascularization in rabbits. Cornea 35(12):1615\u20131620","journal-title":"Cornea"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-017-0786-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0786-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0786-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T06:55:12Z","timestamp":1567234512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-017-0786-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1007\/s10792-017-0786-x","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]},"assertion":[{"value":"12 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that he\/she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}